FN1 and lung carcinoma: Here, we created an antibody that specifically targets CTSV, which inhibited lung cancer cells’ adhesion, migration, and invasion by cleaving fibronectin, E-cadherin, and N-cadherinMore critically, overexpression of CTSV has been shown to suppress T cell function in lung cancer and is adversely correlated with immune cells penetrating tumors.